DArena G, Vitale C, Pietrantuono G, Villani O, Mansueto G, DAuria F
Cancers (Basel). 2024; 16(2).
PMID: 38275909
PMC: 10814247.
DOI: 10.3390/cancers16020469.
Shen M, Li F, Luo X, Wang Z
Medicine (Baltimore). 2024; 102(52):e36022.
PMID: 38206706
PMC: 10754594.
DOI: 10.1097/MD.0000000000036022.
Nazaret A, Fan J, Lavallee V, Burdziak C, Cornish A, Kiseliovas V
bioRxiv. 2023; .
PMID: 38014231
PMC: 10680623.
DOI: 10.1101/2023.11.11.566719.
Robak T, Krawczynska A, Cebula-Obrzut B, Urbaniak M, Iskierka-Jazdzewska E, Robak P
Cancers (Basel). 2023; 15(18).
PMID: 37760396
PMC: 10527541.
DOI: 10.3390/cancers15184427.
Menakuru S, Roepke J, Siddiqui S
J Hematol. 2023; 12(2):82-86.
PMID: 37187496
PMC: 10181324.
DOI: 10.14740/jh1096.
A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia.
Mehrpouri M, Hosseini M, Jafari L, Mosleh M, Shahabi Satlsar E
Iran Biomed J. 2023; 27(1):15-22.
PMID: 36624655
PMC: 9971714.
DOI: 10.52547/ibj.3275.
Lymphoplasmacytic lymphoma and marginal zone lymphoma involving bone marrow: A diagnostic dilemma. Useful clinicopathological features to accurate the diagnosis.
Garcia-Abellas P, Ferrer Gomez A, Bueno Sacristan D, Piris Villaespesa M, Talavera Yague M, Reguero Callejas M
EJHaem. 2022; 3(4):1181-1187.
PMID: 36467836
PMC: 9713066.
DOI: 10.1002/jha2.573.
Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.
Couette N, Jarjour W, Brammer J, Simon Meara A
Front Oncol. 2022; 12:854499.
PMID: 35747794
PMC: 9209697.
DOI: 10.3389/fonc.2022.854499.
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Alaggio R, Amador C, Anagnostopoulos I, Attygalle A, de Oliveira Araujo I, Berti E
Leukemia. 2022; 36(7):1720-1748.
PMID: 35732829
PMC: 9214472.
DOI: 10.1038/s41375-022-01620-2.
Concurrent Presentation of Hairy Cell Leukemia and Mantle Cell Lymphoma (Leukemic Non-Nodal Variant): An Extremely Rare Composite Lymphoma.
Soliman D, Ibrahim F, Fernyhough L, Murad F, Akiki S
J Hematol. 2022; 11(1):21-28.
PMID: 35356636
PMC: 8929197.
DOI: 10.14740/jh942.
Large granular lymphocytic leukemia: a brief review.
Rahul E, Ningombam A, Acharya S, Tanwar P, Ranjan A, Chopra A
Am J Blood Res. 2022; 12(1):17-32.
PMID: 35291253
PMC: 8918699.
Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach.
Arber D, Hasserjian R, Orazi A, Mathews V, Roberts A, Schiffer C
Am J Hematol. 2022; 97(5):514-518.
PMID: 35179244
PMC: 9303333.
DOI: 10.1002/ajh.26503.
CCR7 in Blood Cancers - Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target.
Cuesta-Mateos C, Terron F, Herling M
Front Oncol. 2021; 11:736758.
PMID: 34778050
PMC: 8589249.
DOI: 10.3389/fonc.2021.736758.
Telomerase () Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia.
Dias Nogueira B, da Costa Pantoja L, da Silva E, Mello Junior F, Teixeira E, Wanderley A
Genes (Basel). 2021; 12(10).
PMID: 34681025
PMC: 8535500.
DOI: 10.3390/genes12101632.
Smoldering adult T-cell leukemia complicated with pneumocystis pneumonia: A case report.
Kawamoto K, Yamasaki M, Taniwaki M, Itagaki M, Daido W, Matsumoto Y
Respir Med Case Rep. 2021; 33:101404.
PMID: 34401255
PMC: 8348172.
DOI: 10.1016/j.rmcr.2021.101404.
De novo chronic lymphocytic leukemia/prolymphocytic leukemia or B-cell prolymphocytic leukemia? The importance of integrating clinico-morphological and immunophenotypic findings in distinguishing chronic lymphoproliferative diseases with circulating....
Chowdhury Z, Khonglah Y, Sarma S, Kalita P
Autops Case Rep. 2021; 11:e2020196.
PMID: 34277479
PMC: 8101659.
DOI: 10.4322/acr.2020.196.
Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia.
Moreira-Nunes C, Mesquita F, Jullyanne de Sousa Portilho A, Mello Junior F, Maues J, da Costa Pantoja L
Sci Rep. 2020; 10(1):21272.
PMID: 33277547
PMC: 7718893.
DOI: 10.1038/s41598-020-78024-8.
Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort.
Degaud M, Baseggio L, Grange B, Manzoni D, Huet S, Callet-Bauchu E
Cancers (Basel). 2019; 11(10).
PMID: 31590326
PMC: 6826630.
DOI: 10.3390/cancers11101495.
First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL).
Alfayez M, Thakral B, Jain P, Ravandi F, Ferrajoli A, Jain N
Leuk Lymphoma. 2019; 61(2):445-449.
PMID: 31566032
PMC: 11752443.
DOI: 10.1080/10428194.2019.1660967.
Smudge cell percentage as a surrogate marker for ZAP-70 expression in patients with chronic lymphocytic leukemia.
Al-Kahiry W, Tawfik H, Sharshira H, Ghanem A, El-Gammal M, Mikhael I
Blood Res. 2018; 53(3):218-222.
PMID: 30310788
PMC: 6170303.
DOI: 10.5045/br.2018.53.3.218.